Lymphotoxin is secreted by human lymphocytes stimulated with phytohemagglutinin in vitro. Combinations ofDEAE-cellulose and Sephadex chromatography, acrylamide gel electrophoresis, and isoelectric focusing were used to purify lymphotoxin 2000-to 4000-fold; 15-25% of the activity has been recovered. Lymphotoxin appears to be a weakly charged molecule(s) of molecular weight about 90,000-100,000 that migrates in Pevikon block electrophoresis as a if-or a2 globulin. It is a discrete molecule(s), because it is completely separable from medium serum proteins and carrieh and phytohemagglatinin proteins. Isoelectric-focusing studies indicate that there may be a limited heterogeneity among lymphotoxin molecules.
Lymphoid cells are central effectors in such important immunologic reactions as graft rejection (1), tumor immunity (2) , and delayed hypersensitivity (3) . All of these reactions appear to share at least two common steps: (a) a recognition step, which requires the interaction of the foreign tissue or graft cell with hypothetical lymphocyte-membrane receptor sites (4, 5) and (b) an effector step, which involves active cellular metabolism and biosynthesis (5) . These events lead, by some unknown mechanism, to the destruction of the foreign cell.
Lymphoid cells from experimental animals and man can be activated in vitro specifically with antigens (6), or nonspecifically with mitogens, e.g. phytohemagglutinin (PHA) (7) , to release various soluble molecules into the cell culture medium. These soluble molecules have been proposed to be effector substances associated with cellular immunity (6, 7) . The treatments and agents that trigger the release of these factors are very broad and unrelated, yet they all induce similar changes in lymphocytes, namely, activation of RNA and protein synthesis and morphologic changes associated with transformation (8) . One of these factors is a cell toxin termed lymphotoxin (LT). A few of the physical properties of a cell toxin released by normal human lymphocytes stimulated with PHA in vitro were reported (9) . The toxin appeared to be a protein of molecular weight about 80,000 (9) . This is a brief description of the methods for purification and some physical properties of LT released by human lymphocytes stimulated with PHA in vitro.
MATERIALS AND METHODS
Production of Human Lymphotoxin and Control Media. The details of these methods have been published (10) . Cells were maintained in medium RPMI 1640 (from GIBCO), Abbreviations: LT, lymphotoxin; PHA, phytohemagglutinin.
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containing 0.1% bovine-serum albumin, at a density of 5 X 106 cells per ml, in 32-oz prescription bottles, 200 ml per bottle, then 20 .g of PHA-P (Difco, Detroit, Mich., Lot no. 561822) per ml was added. After 5 days, the medium was collected, pooled, then cleared of cells and debris by centrifugatioh. Controls consisted of either lymphocytes cultured under identical conditions without the addition of PHA, or heat-killed lymphocytes (56°for 30 min) with 20 fg of PHA added at the time the cultures were established. After collection, the medium was concentrated twentyfold by ultrafiltration.
DEAE-Cellulose Column Chromatography. Previously washed
Whatman DE-1 1 resin was poured into a 3.4 X 60-cm column and pressure packed (10 lb/in2) to a bed height of 30 ccm. The columns were equilibrated with 10 mM Trist HCl, (pH 8.0)-25 mM NaCl-0.1 mM EDTA buffer (low salt buffer). 100 ml (2 grams of protein) of concentrated toxic or control medium, previously dialyzed against low salt buffer and clarified by centrifugation, was applied to the column. Proteins were eluted from the column in a linear salt gradient from 25 mM to 350 mM NaCl in 10 mM Trism HCl (pH 8 Pevikon Block Electrophoresis. Zone electrophoresis was performed as described by Muller-Eberhard and Osterlund (12) . 60 mg or 3 ml of 20-times concentrated crude LT or control medium was loaded 5 inches from the cathode on a 5 X 17 X 1/2-inch Pevikon block. Electrophoresis was performed at 40 in barbitol buffer (pH 8.6) for about 20 hr at 400 V and 60 mA until the bromphenol blue marker had migrated 15 inches from the origin. The block was then cut into 0.5-inch strips, and the sample was eluted with 0.15 M NaCl solution. The absorbance of each fraction was measured at 280 nm and, in addition, the amount of protein in each fraction was determined by the Folin-Lowry method (13). Fractions containing each peak were dialyzed against low salt buffer, pooled, lyophilized, and reconstituted in distilled water. Then, each sample was subjected to immunoelectrophoresis (14) .
Preparative Polyacrylamide Disc Electrophoresis. Test and control DEAE-cellulose fractions were subjected to preparative polyacrylamide gel electrophoresis in our modification of the apparatus designed by Furlong et al. (15) . A 6-cm layer of 7% polyacrylarnide was first allowed to gel in a 1.5 X 12-cm glass column. Then, a 1-cm stacking gel was polymerized on top. A glass column of 1.5 X 2 cm was completely filled with a solution of 7% acrylamide. After polymerization, one end was covered with a piece of dialysis tubing. The short and long units were then joined together with a sleeve containing two elution ports, one on each side. 15 mg of LT containing the DEAE-cellulose fraction in 30% glycerol was added to the top of the column and covered with buffer. Electrophoresis was performed at 40 with a constant current of 7 mA in glycine buffer (pH 9), and fractions were eluted at a constant flow rate of one drop every 11 sec. 0.5-ml Fractions were collected, and absorbance was determined at 280 nm.
Isoelectric Focusing. These experiments were performed in 1% ampholine (pH 3-10) (16) . Control Studies with protein-free and protein-containing media revealed that addition of bovine-serum albumin carrier (0.1%) to the initial culture medium helped protect the LT during the initial harvesting, storage, and concentration steps.
DEAE-cellulose is an ion-exchange resin that binds proteins with an overall negative charge. The proteins can then be differentially eluted from the column with an increasing gradient of cations. The location of LT activity after fractionation on DEAE-cellulose is shown in Fig. 1 . LT activity eluted from the column with hemoglobin and before the bovine-serum albumin carrier. Fig. 1 albumin marker, and the other tubes contained the LT samples. Typical results of these studies are shown in Fig. 3 . It is clear that LT sediments just in front of the albumin marker.
Block electrophoresis This is a method for separation or comparison of materials by observation of their migration in an electric field. The electrophoretic mobility of human LT was determined; the wellknown migration pattern of human serum proteins was used as reference. 20-Times concentrated crude medium was used in both test and control separations. A typical result representative of nine separate tests is shown in Fig. 4 . Each of the 280-nm absorbance peaks were identified in agar-slide immunoelectrophoresis, with rabbit antiserum directed against specific human serum proteins. LT activity migrated as a broad band, which localized in the region of the j3-and a2 globulins. Although the total protein recovery was good, there was only a 25-50% recovery of LT activity. Moreover, when all fractions were pooled, concentrated, and tested, original activity was not regained. geneity among molecules with LT activity, because elution patterns were sometimes broad. This is supported by the broad spread of LT activity (pH 6.8-8.0) observed in isoelectric focusing experiments. Human LT is clearly separable from all carriers, serum proteins, and medium factors. With the combinations of DEAE-cellulose, Sephadex, and, finally, either the acrylamide gel electrophoresis or isoelectric focusing, degrees of purification in excess of 2000-to 4000-fold have been achieved, with 15-25% recovery of the original activity.
The role of factors released by lymphocytes in cell-mediated immune reactions in vivo and in vitro is still unclear. Purification and characterization of LT will greatly facilitate our ability to (a) determine the relationship of LT to the other lymphocyte effector molecules and (b) prepare specific blocking agents to provide the means whereby we can begin to elucidate the actual role assignable to this factor in cell-mediated reactions.
Immunology: Gmnger et al. 
